From the June 2017 issue of Icahn School of Medicine at Mount Sinai's Focus on Healthy Aging (FHA)
Blood Thinners: Balancing the Benefits and Risks
These lifesaving drugs require careful management.
You are trying to access subscriber-only content.
If you are a subscriber, .
If you are not a subscriber, or are only subscribed to the print edition, click here to subscribe now. Digital subscribers have unlimited access to our magazine articles and more!
So-called “blood thinners” (anticoagulant drugs) can help prevent dangerous blood clots in people with the abnormal heart rhythm atrial fibrillation (AFib), in which the atria (the upper chambers of the heart) beat irregularly and ineffectively. “This causes blood to pool in the atria,” says Jonathan Halperin, MD, director of clinical cardiology services at Mount Sinai’s […]